Bioray Biotech Co., Ltd (TPEX: 7561)
Taiwan
· Delayed Price · Currency is TWD 21.30
0.00 (0.00%)
Dec 31, 2024, 2:21 PM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 662.30 million as of January 2, 2025. Its market cap has decreased by -24.99% in one year.
Market Cap
662.30M
Enterprise Value
612.51M
Revenue
183.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.30
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 662.30M, a decrease of -65.87%. That is a compound annual growth rate of -21.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2025 | 662.30M | 4.23% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | 826.00M | -57.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 204.36B |
| Lotus Pharmaceutical | 71.47B |
| Oneness Biotech | 41.68B |
| Lumosa Therapeutics | 41.22B |
| Polaris Group | 34.06B |
| Center Laboratories | 31.59B |
| Pegavision | 29.41B |
| TaiMed Biologics | 23.48B |